GlassScriptPhysician profile
Sonia Mvuemba
NPI 1841633542
$7,951.25
in general payments reported to CMS, 2019-2025
23 companies · $854 in 2025
The $854 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,506 · 2020: $203 · 2021: $895 · 2022: $2,771 · 2023: $720 · 2024: $1,002 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,576.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,874.42 | 2019-2025 | Citrefix, Actishield, 7 X 23mm Citrelock Implant |
| Musculoskeletal Transplant Foundation INC. | $1,576.00 | 2021-2025 | |
| Kerecis Limited | $511.84 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Osteomed LLC | $390.30 | 2019-2022 | |
| Ossio INC | $254.02 | 2022-2023 | |
| Integra Lifesciences Corporation | $242.53 | 2021-2022 | |
| Polynovo North America LLC | $200.05 | 2024-2025 | Novosorb Btm |
| Bioventus LLC | $146.96 | 2022 | |
| Organogenesis INC. | $129.58 | 2022 | |
| Zimmer Biomet Holdings, INC. | $119.89 | 2020-2022 | |
| Misonix INC | $105.70 | 2021 | |
| Boston Scientific Corporation | $83.93 | 2020 | |
| Solventum Corporation | $80.00 | 2025 | V.A.C.Ulta, V.A.C.Instill, Activ.A.C. |
| Smith+Nephew, INC. | $38.31 | 2021-2025 | Grafix Pl, Stravix Pl |
| Orthofix Medical, INC. | $37.05 | 2023 | Truelok |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $25.23 | 2023 | Proclaim |
| Paragon 28, INC. | $24.51 | 2021 | |
| Mimedx Group, INC. | $23.75 | 2025 | |
| Next Science LLC | $22.64 | 2023 | Xperience, Surgx, Blastx |
| Dynasplint Systems INC. | $21.78 | 2019 | |
| Treace Medical Concepts, INC. | $16.33 | 2024 | |
| Averitas Pharma INC. | $13.84 | 2025 | Qutenza |
| Royal Biologics, INC. | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Mvuemba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.